BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 23879724)

  • 1. Beta-Hydroxyisovaleryl-Shikonin Eradicates Epithelial Cell Adhesion Molecule-Positive Liver Cancer Stem Cells by Suppressing dUTP Pyrophosphatase Expression.
    Asahina Y; Takatori H; Nio K; Okada H; Hayashi T; Hayashi T; Hashiba T; Suda T; Nishitani M; Sugimoto S; Honda M; Kaneko S; Yamashita T
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines.
    Kimura O; Takahashi T; Ishii N; Inoue Y; Ueno Y; Kogure T; Fukushima K; Shiina M; Yamagiwa Y; Kondo Y; Inoue J; Kakazu E; Iwasaki T; Kawagishi N; Shimosegawa T; Sugamura K
    Cancer Sci; 2010 Oct; 101(10):2145-55. PubMed ID: 20707805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.
    Tan JL; Li F; Yeo JZ; Yong KJ; Bassal MA; Ng GH; Lee MY; Leong CY; Tan HK; Wu CS; Liu BH; Chan TH; Tan ZH; Chan YS; Wang S; Lim ZH; Toh TB; Hooi L; Low KN; Ma S; Kong NR; Stein AJ; Wu Y; Thangavelu MT; Suzuki A; Periyasamy G; Asara JM; Dan YY; Bonney GK; Chow EK; Lu GD; Ng HH; Kanagasundaram Y; Ng SB; Tam WL; Tenen DG; Chai L
    Gastroenterology; 2019 Dec; 157(6):1615-1629.e17. PubMed ID: 31446059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tazemetostat decreases β-catenin and CD13 protein expression in HEPG-2 and Hepatitis B virus-transfected HEPG-2 with decreased cell viability.
    Amin MN; El-Far YM; El-Mowafy M; Elgaml A
    Clin Epigenetics; 2023 Nov; 15(1):180. PubMed ID: 37941056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial activation of EpCAM cleavage via cell-to-cell contact.
    Denzel S; Maetzel D; Mack B; Eggert C; Bärr G; Gires O
    BMC Cancer; 2009 Nov; 9():402. PubMed ID: 19925656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
    Lee OW; Austin S; Gamma M; Cheff DM; Lee TD; Wilson KM; Johnson J; Travers J; Braisted JC; Guha R; Klumpp-Thomas C; Shen M; Hall MD
    SLAS Discov; 2020 Jan; 25(1):9-20. PubMed ID: 31498718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCI Program for Natural Product Discovery: A Publicly-Accessible Library of Natural Product Fractions for High-Throughput Screening.
    Thornburg CC; Britt JR; Evans JR; Akee RK; Whitt JA; Trinh SK; Harris MJ; Thompson JR; Ewing TL; Shipley SM; Grothaus PG; Newman DJ; Schneider JP; Grkovic T; O'Keefe BR
    ACS Chem Biol; 2018 Sep; 13(9):2484-2497. PubMed ID: 29812901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs.
    Hafner M; Niepel M; Chung M; Sorger PK
    Nat Methods; 2016 Jun; 13(6):521-7. PubMed ID: 27135972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Cancer Institute (NCI) Program for Natural Products Discovery: Rapid Isolation and Identification of Biologically Active Natural Products from the NCI Prefractionated Library.
    Grkovic T; Akee RK; Thornburg CC; Trinh SK; Britt JR; Harris MJ; Evans JR; Kang U; Ensel S; Henrich CJ; Gustafson KR; Schneider JP; O'Keefe BR
    ACS Chem Biol; 2020 Apr; 15(4):1104-1114. PubMed ID: 32223208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Molecular Networking Strategy: High-Throughput Screening and Chemical Analysis of Brazilian Cerrado Plant Extracts against Cancer Cells.
    Cortelo PC; Demarque DP; Dusi RG; Albernaz LC; Braz-Filho R; Goncharova EI; Bokesch HR; Gustafson KR; Beutler JA; Espindola LS
    Cells; 2021 Mar; 10(3):. PubMed ID: 33804755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR characterization of rearranged staurosporine aglycone analogues from the marine sponge Damiria sp.
    Tran TD; Cartner LK; Bokesch HR; Henrich CJ; Wang XW; Mahidol C; Ruchirawat S; Kittakoop P; O'Keefe BR; Gustafson KR
    Magn Reson Chem; 2021 May; 59(5):534-539. PubMed ID: 31379005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Polyamidoamine Dendrimer-Based Electrochemical Immunosensor for Label-Free Determination of Epithelial Cell Adhesion Molecule- Expressing Cancer Cells.
    Xu J; Wang X; Yan C; Chen W
    Sensors (Basel); 2019 Apr; 19(8):. PubMed ID: 31010258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US National Cancer Institute-China Collaborative Studies on Chinese Medicine and Cancer.
    Jia L; Lin H; Oppenheim J; Howard OMZ; Li J; Fan H; Zhao Z; Farrar W; Zhang Y; Colburn N; Young MR; Li W; Newman D; O'Keefe BR; Beutler J; Liu J; Hao X; Yang X; Ji T; White JD
    J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide.
    Fako V; Yu Z; Henrich CJ; Ransom T; Budhu AS; Wang XW
    Int J Biol Sci; 2016; 12(7):768-75. PubMed ID: 27313491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma.
    Takai A; Fako V; Dang H; Forgues M; Yu Z; Budhu A; Wang XW
    Sci Rep; 2016 Feb; 6():21174. PubMed ID: 26880118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells.
    Henrich CJ; Budhu A; Yu Z; Evans JR; Goncharova EI; Ransom TT; Wang XW; McMahon JB
    Chem Biol Drug Des; 2013 Aug; 82(2):131-9. PubMed ID: 23879724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T; Budhu A; Forgues M; Wang XW
    Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.
    Yamashita T; Ji J; Budhu A; Forgues M; Yang W; Wang HY; Jia H; Ye Q; Qin LX; Wauthier E; Reid LM; Minato H; Honda M; Kaneko S; Tang ZY; Wang XW
    Gastroenterology; 2009 Mar; 136(3):1012-24. PubMed ID: 19150350
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.